Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00784563 · ClinicalTrials.gov registry record · NA

Effects of Aerobic Exercise in Parkinson's Disease

A NA study of Parkinson Disease, sponsored by US Department of Veterans Affairs.

Completed
Registry status
NA
Development phase
104
Enrollment target
1
Study location

NCT00784563: Completed NA study of Parkinson Disease, sponsored by US Department of Veterans Affairs.

NCT00784563 is a NA study of Parkinson Disease that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 104 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00784563, a NA study of Parkinson Disease, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
NA
Development phase
104 participants
Enrollment target
1
Study location

Study Summary

Motivated by reported improvements in aerobic fitness and executive functions after a 6-month aerobic walking intervention in normal sedentary elderly, we conducted a Phase I/II study to investigate effects of aerobic exercise on motor function, cognition, and quality of life in mild-moderate patients with Parkinson's disease (PD). To identify the best method to deliver fitness training, we also aimed to compare safety, tolerability, and fitness benefits between different training methods (continuous/moderate intensity vs. interval/alternating between low and vigorous intensity) and exercise settings (individual vs. group). Interval training reportedly facilitates higher fitness gains than continuous training. Group training may promote success through social interaction, whereas individual training offers greater flexibility. Details of the study can be found in the publication below: Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting. Uc EY, Doerschug KC, Magnotta V, Dawson JD, Thomsen TR, Kline JN, Rizzo M, Newman SR, Mehta S, Grabowski TJ, Bruss J, Blanchette DR, Anderson SW, Voss MW, Kramer AF, Darling WG. Neurology. 2014 Jul 29;83(5):413-25. doi: 10.1212/WNL.0000000000000644. Epub 2014 Jul 2. PMID: 24991037

Primary Outcome

VO2max after the training - VO2max at baseline (Adjusted for levodopa-equivalent, year, training mode, setting). Please see publication PMID: 24991037 for details.

Conditions Studied

Interventions

  • BEHAVIORAL Continuous training
  • BEHAVIORAL Interval training

Study Locations (1)

Iowa

  • VA Medical Center, Iowa City - Iowa City

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2009-02
Est. Completion 2012-05
Phase NA
US Department of Veterans Affairs

632 total trials

What the finished NCT00784563 record still lists

NCT00784563 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Continuous training is the first listed.

NCT00784563 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT00784563 about?

NCT00784563 is a clinical study titled "Effects of Aerobic Exercise in Parkinson's Disease". Motivated by reported improvements in aerobic fitness and executive functions after a 6-month aerobic walking intervention in normal sedentary elderly, we conducted a Phase I/II study to investigate effects of aerobic exercise on motor function, cognition, and quality of life in mild-moderate patien...

What is the current status of trial NCT00784563?

This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2009-02. Estimated completion is 2012-05.

What conditions does trial NCT00784563 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT00784563?

The interventions under investigation include: Continuous training (BEHAVIORAL), Interval training (BEHAVIORAL).

Who is sponsoring clinical trial NCT00784563?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00784563 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00784563's enrollment target sits among peer trials

104 84th of 297 higher than 214 of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03403686 · 104 participants

    Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

  • NCT04228367 · 104 participants · NA

    JuggerStitch Post Market Clinical Follow-up Study

  • NCT04268849 · 104 participants · Phase 3

    Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

  • NCT04390724 · 104 participants

    Optimizing Y90 Therapy for Radiation Lobectomy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00784563, the US trial registry maintained by the National Library of Medicine. NCT00784563 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.